MLPFX
Price
$11.21
Change
+$0.01 (+0.09%)
Updated
Sep 11 closing price
Net Assets
2.46B
TMCLX
Price
$10.99
Change
-$0.01 (-0.09%)
Updated
Sep 11 closing price
Net Assets
161.01M
Interact to see
Advertisement

MLPFX vs TMCLX

MLPFX vs TMCLX Comparison Chart in %
View a ticker or compare two or three
VS
MLPFX vs. TMCLX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLPFX is a Hold and TMCLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MLPFX has more cash in the bank: 2.46B vs. TMCLX (161M). MLPFX pays higher dividends than TMCLX: MLPFX (5.09) vs TMCLX (2.45). MLPFX was incepted earlier than TMCLX: MLPFX (16 years) vs TMCLX (13 years). TMCLX (2.35) is less costly to investors than MLPFX (1.45). TMCLX is a more actively managed with annual turnover of: 53.00 vs. MLPFX (14.00). MLPFX (1000) and TMCLX (1000) have matching initial minimum investment requirements. MLPFX annual gain was more profitable for investors over the last year : 33.03 vs. TMCLX (28.16). MLPFX return over 5 years is better than : 190.95 vs. TMCLX (102.42).
MLPFXTMCLXMLPFX / TMCLX
Total Expense Ratio1.442.3561%
Annual Report Gross Expense Ratio1.452.3562%
Fund Existence16 years13 years-
Gain YTD29.60727.722107%
Front Load6%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.46B161M1,530%
Annual Yield % from dividends5.092.45208%
Returns for 1 year33.0328.16117%
Returns for 3 years97.2283.22117%
Returns for 5 years190.95102.42186%
Returns for 10 years169.2389.33189%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ARKK83.580.52
+0.63%
ARK Innovation ETF
BAMO34.820.20
+0.59%
Brookstone Opportunities ETF
AVK12.230.07
+0.58%
Advent Convertible and Income Fund
AVMU43.780.16
+0.37%
Avantis Core Municipal Fixed Inc ETF
THNR25.59-0.41
-1.59%
Amplify Weight Loss Drug & Treatment ETF